These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1091044)

  • 1. Adrenocorticosteroids in lupus nephritis.
    Ginzler EM; Kaplan D
    Transplant Proc; 1975 Mar; 7(1):109-12. PubMed ID: 1091044
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenic role of anti-DNA antibodies in murine lupus nephritis.
    Granholm NA; Graves K; Izui S; Cavallo T
    J Clin Lab Immunol; 1985 Nov; 18(3):113-8. PubMed ID: 3878885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenetic significance of antinuclear factors].
    Beickert A
    Z Gesamte Inn Med; 1972 Oct; 27(19):816-20. PubMed ID: 4539612
    [No Abstract]   [Full Text] [Related]  

  • 4. Lupus Nephritis.
    Adu D; Cameron JS
    Clin Rheum Dis; 1982 Apr; 8(1):153-82. PubMed ID: 6214362
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic lupus erythematosus.
    Goust JM; Tsokos G
    Immunol Ser; 1993; 58():437-49. PubMed ID: 8424987
    [No Abstract]   [Full Text] [Related]  

  • 6. [Systemic lupus erythematosus and antinuclear factors, with special reference to its diagnostic significance and relationship to the etiology of lupus nephritis].
    Nagasawa T
    Saishin Igaku; 1969 Oct; 24(10):2082-96. PubMed ID: 5307586
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
    Mackay IR
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1211-7. PubMed ID: 4139686
    [No Abstract]   [Full Text] [Related]  

  • 8. The natural history and response to therapy of lupus nephritis.
    Ginzler EM; Bollet AJ; Friedman EA
    Annu Rev Med; 1980; 31():463-87. PubMed ID: 6994624
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nephritis and the presence of antiribonucleoprotein antibodies in disseminated lupus erythematosus in children and adolescents].
    Lapointe ND; Carrenö-Perrez L; Pelletier M; Déom P; Robitaille P
    Union Med Can; 1985 Jun; 114(6):490-2. PubMed ID: 3875176
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice.
    Shirai T; Hirose S; Sekigawa I; Okada T; Sato H
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():11-20. PubMed ID: 3497267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus--immunoregulatory therapies.
    Miller ML; Steinberg AD
    Clin Rheum Dis; 1983 Dec; 9(3):617-28. PubMed ID: 6360516
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis.
    Yoshida H; Yoshida M; Izui S; Lambert PH
    J Clin Invest; 1985 Aug; 76(2):685-94. PubMed ID: 3875630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes.
    Termaat RM; Assmann KJ; van Son JP; Dijkman HB; Koene RA; Berden JH
    Lab Invest; 1993 Feb; 68(2):164-73. PubMed ID: 7680080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current concepts on the pathogenesis of lupus nephritis].
    Tareeva IE
    Arkh Patol; 1973; 35(6):74-82. PubMed ID: 4361708
    [No Abstract]   [Full Text] [Related]  

  • 18. Murine lupus nephritis. Effects of glucocorticoid on circulating and tissue-bound immunoreactants.
    Cavallo T; Graves K; Granholm NA
    Lab Invest; 1983 Oct; 49(4):476-81. PubMed ID: 6604840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of avidity of circulating anti-DNA antibodies on murine lupus nephritis.
    Granholm NA; Graves K; Cavallo T
    J Clin Lab Immunol; 1985 Apr; 16(4):211-5. PubMed ID: 4020851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):769-72. PubMed ID: 6983871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.